Maen Alnajjar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maen Alnajjar has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad Nawlo
Faculty of Medicine, University of Aleppo, Aleppo, Syria
1 shared publication Hani Alloush
Department of Orthopaedic Surgery, Faculty of Medicine, Aleppo University Hospital, University of Aleppo, Aleppo, Syria
1 shared publication- Mohamad Ali Farho
Faculty of Medicine, University of Aleppo, Aleppo, Syrian Arab Republic
1 shared publication - Mohamad Nabhan Sawas
University of Aleppo, Faculty of Medicine Aleppo Syrian Arab Republic
1 shared publication - Mohammed Al-Mahdi Al-Kurdi
Faculty of Medicine, University of Aleppo, Aleppo, Syria
1 shared publication
Latest Publications
- Open Access
- 1 July 2023
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 108, 108411
Subtrochanteric fracture in previously treated breast cancer patient handled by proximal femoral nail: A case report
Breast cancer (BC) is the most common and high mortality rate cancer in females. The main complication of BC is metastases, where bone metastases (BM) are present in 90 % of women with distant metastases and commonly recurrence after BC therapy. However, treatment options are numerous, and improving patients' quality of life (QoL) is a priority. A 58-year-old female patient presented to the emergency department with pain and movement restriction in the right lower extremity after minor trauma. Clinical history included a surgically resected BC eight years ago, besides chemotherapy and radiotherapy. After clinical and radiographic examination, we encountered a subtrochanteric femoral fracture although the patient is in the end stage, the multidisciplinary team discussed the surgery option with the patient and eventually internally fixed the fracture. Subtrochanteric femur fractures represent a challenging orthopedic issue, ranging from 10 % to 34 % of all hip fractures. Hence, after a detailed discussion, the proximal femoral nail (PFN) was the procedure of choice acording to the patient's preferences and tumor prognosis. Proximal femoral metastasis treatment aims to improve the quality of life (QoL), alleviate bone pain, and rehabilitate skeletal function. In this case report, we highlight the surgical decision consequences for a patient with end-stage cancer, as it may put their life at risk or improve their QoL, likewise the patient in this report.
- 1 July 2023
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 108, 108411
Open AccessSubtrochanteric fracture in previously treated breast cancer patient handled by proximal femoral nail: A case report
Breast cancer (BC) is the most common and high mortality rate cancer in females. The main complication of BC is metastases, where bone metastases (BM) are present in 90 % of women with distant metastases and commonly recurrence after BC therapy. However, treatment options are numerous, and improving patients' quality of life (QoL) is a priority. A 58-year-old female patient presented to the emergency department with pain and movement restriction in the right lower extremity after minor trauma. Clinical history included a surgically resected BC eight years ago, besides chemotherapy and radiotherapy. After clinical and radiographic examination, we encountered a subtrochanteric femoral fracture although the patient is in the end stage, the multidisciplinary team discussed the surgery option with the patient and eventually internally fixed the fracture. Subtrochanteric femur fractures represent a challenging orthopedic issue, ranging from 10 % to 34 % of all hip fractures. Hence, after a detailed discussion, the proximal femoral nail (PFN) was the procedure of choice acording to the patient's preferences and tumor prognosis. Proximal femoral metastasis treatment aims to improve the quality of life (QoL), alleviate bone pain, and rehabilitate skeletal function. In this case report, we highlight the surgical decision consequences for a patient with end-stage cancer, as it may put their life at risk or improve their QoL, likewise the patient in this report.